Erratum: Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor (Clinical and Translational Oncology DOI: 10.1007/s12094-012-0985-x)

1. Afonso, F.J.
2. Anido, U.
3. Fernández-Calvo, O.
4. Vázquez-Estévez, S.
5. León, L.
6. Lázaro, M.
7. Ramos, M.
8. Antón-Aparicio, L.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1007/S12094-013-1032-2 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus